Machine Learning-Based Interpretation and Visualization of Nonlinear Interactions in Prostate Cancer Survival
Richard Li1, Ashwin Shinde1, An Liu1
1Department of Radiation Oncology, City of Hope Medical Center, Duarte, CA.
JCO Clinical Cancer Informatics
|July 17, 2020
Summary
Shapley additive explanation (SHAP) values offer a consistent way to interpret machine learning models. This study applies SHAP to predict prostate cancer mortality risk, revealing novel interactions between Gleason score and percent positive cores.
Area of Science:
- Machine learning applications in oncology
- Predictive modeling for cancer outcomes
- Explainable artificial intelligence in healthcare
Background:
- Prostate cancer risk stratification relies on clinical and pathological factors.
- Accurate prediction of mortality risk is crucial for treatment decisions.
- Interactions between prognostic factors can be complex and difficult to model.
Purpose of the Study:
- To apply Shapley additive explanation (SHAP) values for predicting mortality risk in prostate cancer.
- To utilize SHAP values to model and visualize nonlinear interaction effects between prognostic factors.
- To explore the utility of machine learning interpretability methods in refining prostate cancer staging.
Main Methods:
- Utilized the National Cancer Database to identify 372,808 patients with nonmetastatic, node-negative prostate cancer (2004-2015).
- Trained a gradient-boosted tree model incorporating features: age, prostate-specific antigen (PSA), Gleason score, percent positive cores (PPC), comorbidity score, and clinical T stage.
- Applied SHAP values to interpret model predictions and analyze feature interactions using Python 3.7 open-source libraries.
Main Results:
- SHAP analysis confirmed known interactions, such as low PSA and high Gleason score predicting poor prognosis.
- A novel finding demonstrated stronger interaction effects between PPC and Gleason score (≥8) compared to Gleason 6-7, especially with PPC ≥50%.
- Confirmatory analyses showed significantly lower 5-year overall survival in Gleason ≥8 patients with PPC ≥50% (77.2%) versus PPC <50% (87.7%), P < .001.
Conclusions:
- Shapley additive explanation (SHAP) values provide a powerful method for modeling and visualizing nonlinear interactions in prostate cancer.
- This machine learning-based approach shows promise for enhancing risk stratification and staging systems.
- The findings highlight the importance of considering the interplay between percent positive cores and Gleason score in predicting prostate cancer outcomes.
Related Concept Videos
Cancer Survival Analysis
568
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
568
Comparing the Survival Analysis of Two or More Groups
468
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
468
Kaplan-Meier Approach
457
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
457


